AbCellera Biologics Inc (ABCL)
2.83
-0.12
(-4.07%)
USD |
NASDAQ |
Nov 26, 16:00
2.825
0.00 (0.00%)
After-Hours: 20:00
AbCellera Biologics Market Cap: 835.89M for Nov. 26, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 26, 2024 | 835.89M |
| November 25, 2024 | 871.33M |
| November 22, 2024 | 815.21M |
| November 21, 2024 | 803.40M |
| November 20, 2024 | 788.63M |
| November 19, 2024 | 800.44M |
| November 18, 2024 | 782.72M |
| November 15, 2024 | 782.72M |
| November 14, 2024 | 815.21M |
| November 13, 2024 | 862.47M |
| November 12, 2024 | 874.28M |
| November 11, 2024 | 930.40M |
| November 08, 2024 | 797.49M |
| November 07, 2024 | 803.40M |
| November 06, 2024 | 815.21M |
| November 05, 2024 | 803.40M |
| November 04, 2024 | 853.61M |
| November 01, 2024 | 806.35M |
| October 31, 2024 | 806.35M |
| October 30, 2024 | 820.54M |
| October 29, 2024 | 835.30M |
| October 28, 2024 | 853.01M |
| October 25, 2024 | 802.83M |
| October 24, 2024 | 796.93M |
| October 23, 2024 | 820.54M |
| Date | Value |
|---|---|
| October 22, 2024 | 838.25M |
| October 21, 2024 | 817.59M |
| October 18, 2024 | 847.10M |
| October 17, 2024 | 791.02M |
| October 16, 2024 | 773.31M |
| October 15, 2024 | 755.60M |
| October 14, 2024 | 743.80M |
| October 11, 2024 | 764.46M |
| October 10, 2024 | 737.89M |
| October 09, 2024 | 734.94M |
| October 08, 2024 | 758.55M |
| October 07, 2024 | 776.26M |
| October 04, 2024 | 737.89M |
| October 03, 2024 | 731.99M |
| October 02, 2024 | 731.99M |
| October 01, 2024 | 758.55M |
| September 30, 2024 | 767.41M |
| September 27, 2024 | 769.08M |
| September 26, 2024 | 754.34M |
| September 25, 2024 | 718.98M |
| September 24, 2024 | 742.56M |
| September 23, 2024 | 730.77M |
| September 20, 2024 | 763.18M |
| September 19, 2024 | 807.38M |
| September 18, 2024 | 810.33M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
704.25M
Minimum
Sep 06 2024
15.64B
Maximum
Dec 11 2020
3.348B
Average
2.440B
Median
Market Cap Benchmarks
| Aurinia Pharmaceuticals Inc | 1.247B |
| Edesa Biotech Inc | 7.177M |
| Lexaria Bioscience Corp | 33.68M |
| InMed Pharmaceuticals Inc | 3.253M |
| Xenon Pharmaceuticals Inc | 3.236B |
Market Cap Related Metrics
| PS Ratio | 25.16 |
| PEG Ratio | -0.1305 |
| Price to Book Value | 0.7753 |
| Price | 2.83 |
| Earnings Yield | -21.55% |
| PEGY Ratio | -0.1305 |